Centene reevaluating international fronts as US market grows

Centene is considering divesting “strategic alternatives” for “non-core assets,” including its international ventures, in an effort to streamline its business portfolio, according to a Dec. 10 news release. 

Advertisement

The payer’s international reach includes the United Kingdom and Spain, with over $2 billion in annual revenue between health plans and hospitals it owns, according to its Dec. 10 Investor Day presentation. The portion is a fraction of its estimated $125.2 billion to $126.4 billion in anticipated revenue for 2021. 

The divestment news comes as Centene looks to bolster its business in the United States.

As 2021 comes to a close, Centene looks to finalize its acquisition of Phoenix-based behavioral health provider Magellan Health. The payer also anticipates up to $137.9 billion in revenue for 2022.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Strategy

Advertisement

Comments are closed.